A detailed history of Acadian Asset Management LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 165,770 shares of HLVX stock, worth $341,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165,770
Previous 410,257 59.59%
Holding current value
$341,486
Previous $848,000 71.7%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 21, 2025

SELL
$1.45 - $2.14 $354,506 - $523,202
-244,487 Reduced 59.59%
165,770 $240,000
Q4 2024

Feb 11, 2025

SELL
$1.72 - $2.06 $262,561 - $314,463
-152,652 Reduced 27.12%
410,257 $848,000
Q3 2024

Nov 12, 2024

BUY
$1.58 - $14.42 $889,396 - $8.12 Million
562,909 New
562,909 $989,000

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $68.9M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.